[1] |
SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics,2022[J]. CA Cancer J Clin, 2022, 72(1):7-33. doi:10.3322/caac.21708.
|
[2] |
BABJUK M, BURGER M, COMPÉRAT E M, et al. European Association of Urology Guidelines on non-muscle-invasive bladder cancer(TaT1 and Carcinoma In Situ)- 2019 Update[J]. Eur Urol, 2019, 76(5):639-657. doi:10.1016/j.eururo.2019.08.016.
|
[3] |
WITJES J A, BRUINS H M, CATHOMAS R, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer:Summary of the 2020 Guidelines[J]. Eur Urol, 2021, 79(1):82-104. doi:10.1016/j.eururo.2020.03.055.
|
[4] |
FENG D, BAI Y, YANG Y, et al. Clinicopathological characteristics and treatment outcomes of 162 Chinese patients with metastatic bladder cancer:results from a tertiary teaching hospital[J]. Transl Cancer Res, 2020, 9(8):4870-4878. doi:10.21037/tcr-20-737.
|
[5] |
FU W, WU X, YANG Z, et al. The effect of miR-124-3p on cell proliferation and apoptosis in bladder cancer by targeting EDNRB[J]. Arch Med Sci, 2019, 15(5):1154-1162. doi:10.5114/aoms.2018.78743.
|
[6] |
ZHEN H, DU P, YI Q, et al. LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA[J]. BMC Cancer, 2021, 21(1):1145. doi:10.1186/s12885-021-08882-6.
|
[7] |
HUANG C S, TSAI C H, YU C P, et al. Long noncoding RNA LINC02470 sponges microRNA-143-3p and enhances SMAD3-mediated epithelial-to-mesenchymal transition to promote the aggressive properties of bladder cancer[J]. Cancers(Basel), 2022, 14(4):968. doi:10.3390/cancers14040968.
|
[8] |
ZHOU X, CHANG Y, ZHU L, et al. LINC00839/miR-144-3p/WTAP(WT1 associated protein)axis is involved in regulating hepatocellular carcinoma progression[J]. Bioengineered, 2021, 12(2):10849-10861. doi:10.1080/21655979.2021.1990578.
|
[9] |
ZHANG F Y, LI X, HUANG T T, et al. LINC00839 knockdown restrains the metastatic behavior of nasopharyngeal carcinoma by sponging miR-454-3p[J]. Aging (Albany NY), 2021, 13(24):26022-26033. doi:10.18632/aging.203792.
|
[10] |
QUINN J J, CHANG H Y. Unique features of long non-coding RNA biogenesis and function[J]. Nat Rev Genet, 2016, 17(1):47-62. doi:10.1038/nrg.2015.10.
|
[11] |
佘明豪, 刘寒松, 杨文辉, 等. lncRNA FOXCUT调控Notch通路抑制结肠癌细胞增殖、侵袭的实验研究[J]. 天津医药, 2021, 49(4):354-358.
|
|
SHE M H, LIU H S, YANG W H, et al. Experimental study of lncRNA FOXCUT regulating Notch pathway to inhibit proliferation and invasion of colon cancer cells[J]. Tianjin Med J, 2021, 49(4):354-358. doi:10.11958/20202872.
|
[12] |
余奎杨, 刘攀, 张浩文, 等. LncRNA ZFAS1靶向miR-373导致肝癌细胞顺铂耐药的机制研究[J]. 天津医药, 2022, 50(5):455-460.
|
|
YU K Y, LIU P, ZHANG H W, et al. Study on the mechanism of LncRNA ZFAS1 targeting miR-373 to induce cisplatin resistance in hepatocellular carcinoma cells[J]. Tianjin Med J, 2022, 50(5):455-460. doi:10.11958/20203618.
|
[13] |
CAO H L, LIU Z J, HUANG P L, et al. lncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206[J]. Eur Rev Med Pharmacol Sci, 2019, 23(3):1012-1021. doi:10.26355/eurrev_201902_16988.
|
[14] |
LUO W, WANG J, XU W, et al. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer[J]. Cell Death Dis, 2021, 12(11):1043. doi:10.1038/s41419-021-04296-1.
|
[15] |
YANG L, PEI L, YI J. LINC00839 regulates proliferation,migration,invasion,apoptosis and glycolysis in neuroblastoma cells through miR-338-3p/GLUT1 axis[J]. Neuropsychiatr Dis Treat, 2021, 17:2027-2040. doi:10.2147/NDT.S309467.
|
[16] |
CHEN Q, SHEN H, ZHU X, et al. A nuclear lncRNA Linc00839 as a Myc target to promote breast cancer chemoresistance via PI3K/AKT signaling pathway[J]. Cancer Sci, 2020, 111(9):3279-3291. doi:10.1111/cas.14555.
|
[17] |
YU X, JIANG Y, HU X, et al. LINC00839/miR-519d-3p/JMJD6 axis modulated cell viability,apoptosis,migration and invasiveness of lung cancer cells[J]. Folia Histochem Cytobiol, 2021, 59(4):271-281. doi:10.5603/FHC.a2021.0022.
|
[18] |
LI B, XIE D, ZHANG H. MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2[J]. J Cancer, 2019, 10(12):2628-2634. doi:10.7150/jca.33117.
|
[19] |
WANG S, WU G, HAN Y, et al. miR-124 regulates STAT3-mediated cell proliferation,migration and apoptosis in bladder cancer[J]. Oncol Lett, 2018, 16(5):5875-5881. doi:10.3892/ol.2018.9341.
|
[20] |
HERRMANN E, BÖGEMANN M, BIERER S, et al. The endothelin axis in urologic tumors:mechanisms of tumor biology and therapeutic implications[J]. Expert Rev Anticancer Ther, 2006, 6(1):73-81. doi:10.1586/14737140.6.1.73.
|
[21] |
WÜLFING C, ELTZE E, PIECHOTA H, et al. Expression of endothelin-1 and endothelin-A and -B receptors in invasive bladder cancer[J]. Oncol Rep, 2005, 13(2):223-228.
|